Appendix cancer other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
:* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide | :* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide | ||
:* [[Bone]] [[scintigraphy]] with 99mTc-methylene diphosphonate (99mTcMDP) | :* [[Bone]] [[scintigraphy]] with 99mTc-methylene diphosphonate (99mTcMDP) | ||
:* MIBG scintigraphy <ref name="pmid11158063">Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL et al. (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11158063 Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.] ''J Clin Endocrinol Metab'' 86 (2):895-902. [http://dx.doi.org/10.1210/jcem.86.2.7194 DOI:10.1210/jcem.86.2.7194] PMID: [https://pubmed.gov/11158063 11158063]</ref> | |||
::*distinguish between primary and metastatic tumors. | |||
::*Detecting carcinoid tumors that are negative on OctreoScan | |||
:* [[Positron emission tomography]] (PET) (Figure below demonstrates Post-operative PET-CT scan of a patient with carcinoid tumor.) | :* [[Positron emission tomography]] (PET) (Figure below demonstrates Post-operative PET-CT scan of a patient with carcinoid tumor.) | ||
Revision as of 00:08, 25 January 2019
Appendix cancer Microchapters |
Diagnosis |
---|
Treatment |
Appendix cancer other imaging findings On the Web |
American Roentgen Ray Society Images of Appendix cancer other imaging findings |
Risk calculators and risk factors for Appendix cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Positron emission tomography (PET) and scintigraphy are among other imaging modalities that may be helpful in the diagnosis and management of appendix cancer.
Other Imaging Findings
- The followings are among other imaging modalities that may be helpful in the diagnosis and management of appendix cancer:
- Somatostatin scintigraphy with 111-indium-octreotide
- Bone scintigraphy with 99mTc-methylene diphosphonate (99mTcMDP)
- MIBG scintigraphy [1]
- distinguish between primary and metastatic tumors.
- Detecting carcinoid tumors that are negative on OctreoScan
- Positron emission tomography (PET) (Figure below demonstrates Post-operative PET-CT scan of a patient with carcinoid tumor.)
References
- ↑ Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL et al. (2001) Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86 (2):895-902. DOI:10.1210/jcem.86.2.7194 PMID: 11158063